Summary
This Form 8-K filing from Becton, Dickinson and Company (BDX) on May 1, 2003, reports on significant stock option exercises and subsequent sales by key executives. Specifically, Vincent A. Forlenza, President of BD Biosciences, exercised options for 84,428 shares and sold them all. William A. Kozy, President of BD Clinical Laboratory Solutions and Company Operations, exercised options for 50,000 shares and also sold all of them. William A. Tozzi, Vice President and Controller, exercised options for 9,700 shares and sold 8,400 of them. While these executives have reduced their direct shareholdings through these sales, the filing details their continued ownership of a substantial number of shares through direct holdings and participation in the company's Savings Incentive Plan. Investors should note that these transactions are primarily related to the exercise and sale of vested options and do not necessarily reflect a change in the executives' long-term confidence in the company, but rather a liquidation of those specific vested options.
Key Highlights
- 1Key executives Vincent A. Forlenza and William A. Kozy exercised and sold all shares from their option grants.
- 2William A. Tozzi exercised options and sold a majority of the shares received.
- 3The filings are made under Regulation FD, indicating public disclosure of these executive transactions.
- 4Despite the sales, executives retain significant ownership through direct holdings and savings plans.
- 5Vincent A. Forlenza's post-transaction ownership: 30,529 shares (25,895 direct, 4,633 in savings plan).
- 6William A. Kozy's post-transaction ownership: 37,657 shares (32,944 direct, 4,712 in savings plan).
- 7William A. Tozzi's post-transaction ownership: 8,077 shares (4,149 direct, 3,923 in savings plan).